You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 282 No. 20, November 24, 1999 TABLE OF CONTENTS
  JAMA
  •  Online Features
  Preliminary Communication
 This Article
 •Full text
 •PDF
 •Correction
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on ISI (28)
 •Contact me when this article is cited
 Related Content
 •Related letter
 •Related article
 •Similar articles in JAMA
 Topic Collections
 •Bacterial Infections
 •Infectious Diseases
 •Alert me on articles by topic
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati
What's this?

Borrelia burgdorferi–Specific Immune Complexes in Acute Lyme Disease

Steven E. Schutzer, MD; P. K. Coyle, MD; Patrick Reid, MS; Bart Holland, PhD

JAMA. 1999;282:1942-1946.

Context  Diagnosis of infection with Borrelia burgdorferi, the cause of Lyme disease (LD), has been impeded by the lack of effective assays to detect active infection.

Objective  To determine whether B burgdorferi–specific immune complexes are detectable during active infection in LD.

Design, Setting, and Patients  Cross-sectional analysis of serum samples from 168 patients fulfilling Centers for Disease Control and Prevention surveillance criteria for LD and 145 healthy and other disease controls conducted over 8 years. Tests were performed blinded.

Main Outcome Measure  Detection of B burgdorferi immune complexes by enzyme-linked immunosorbent assay and Western blot.

Results  The B burgdorferi immune complexes were found in 25 of 26 patients with early seronegative erythema migrans (EM) LD; 105 of 107 patients with seropositive EM LD; 6 of 10 patients who were seronegative with culture-positive EM; 0 of 12 patients who were treated and recovered from LD; and 13 of 13 patients with neurologic LD without EM. Among 147 controls, B burgdorferi immune complex was found in 0 of 50 healthy individuals; 0 of 40 patients with persistent fatigue; 0 of 7 individuals with frequent tick exposure; and 2 of 50 patients with other diseases.

Conclusion  These data suggest that B burgdorferi immune complex formation is a common process in active LD. Analysis of the B burgdorferi immune complexes by a simple technique has the potential to support or exclude a diagnosis of early as well as active LD infection.


Author Affiliations: Department of Medicine, Division of Allergy and Immunology (Dr Schutzer and Mr Reid) and Department of Preventive Medicine (Dr Holland), University of Medicine and Dentistry of New Jersey-New Jersey Medical School, Newark (Dr Schutzer and Mr Reid); and the Department of Neurology, State University of New York, Stony Brook (Dr Coyle).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati     What's this?

RELATED LETTER

Serologic Testing for Lyme Disease
Martin E. Schriefer, David T. Dennis, Duane J. Gubler, Edward B. Hayes, Barbara J. B. Johnson, May C. Chu, Steven E. Schutzer, Bart Holland, Patrick Reid, and P. K. Coyle
JAMA. 2000;284(6):695-696.
EXTRACT | FULL TEXT  

RELATED ARTICLE

November 24, 1999
JAMA. 1999;282(20):1979-1980.
EXTRACT | FULL TEXT  


THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Criteria for Validation of Methods in Microbial Forensics
Budowle et al.
Appl. Environ. Microbiol. 2008;74:5599-5607.
FULL TEXT  

Detection of Immune Complexes Is Not Independent of Detection of Antibodies in Lyme Disease Patients and Does Not Confirm Active Infection with Borrelia burgdorferi
Marques et al.
CVI 2005;12:1036-1040.
ABSTRACT | FULL TEXT  

Preferential Presence of Decorin-Binding Protein B (BBA25) and BBA50 Antibodies in Cerebrospinal Fluid of Patients with Neurologic Lyme Disease
Fikrig et al.
J. Clin. Microbiol. 2004;42:1243-1246.
ABSTRACT | FULL TEXT  

Coevolution of Markers of Innate and Adaptive Immunity in Skin and Peripheral Blood of Patients with Erythema Migrans
Salazar et al.
J. Immunol. 2003;171:2660-2670.
ABSTRACT | FULL TEXT  

Host-Adapted Borrelia burgdorferi in Mice Expresses OspA during Inflammation
Crowley and Huber
Infect. Immun. 2003;71:4003-4010.
ABSTRACT | FULL TEXT  

Natural Antibody Affects Survival of the Spirochete Borrelia burgdorferi within Feeding Ticks
Belperron and Bockenstedt
Infect. Immun. 2001;69:6456-6462.
ABSTRACT | FULL TEXT  

Use of Serum Immune Complexes in a New Test That Accurately Confirms Early Lyme Disease and Active Infection with Borrelia burgdorferi
Brunner and Sigal
J. Clin. Microbiol. 2001;39:3213-3221.
ABSTRACT | FULL TEXT  

Serologic Testing for Lyme Disease
Schriefer et al.
JAMA 2000;284:695-696.
FULL TEXT  

Ehrlichiosis in the United States
Byrd et al.
Chest 2000;117:1524-1525.
FULL TEXT  

Borrelia-Specific Immune Complexes Detect Acute Lyme Disease
JWatch Infect. Diseases 2000;2000:18-18.
FULL TEXT  

Early Detection of B. Burgdorferi Immune Complexes in Acute Lyme Disease
Journal Watch Dermatology 2000;2000:5-5.
FULL TEXT  

Immune Complexes May Aid in Lyme Diagnosis
JWatch General 1999;1999:4-4.
FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1999 American Medical Association. All Rights Reserved.